{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:34:55Z","timestamp":1791304495073,"version":"4.3.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1093\/brain\/awu291","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T23:51:26Z","timestamp":1414540286000},"page":"3235-3247","source":"Crossref","is-referenced-by-count":109,"title":["Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation"],"prefix":"10.1093","volume":"137","author":[{"given":"Ianai","family":"Fishbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yien-Ming","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"key":"key\n\t\t\t\t20170425173830_awu291-B1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425173830_awu291-B2","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00018-010-0592-3","article-title":"Synphilin-1 inhibits alpha-synuclein degradation by the proteasome","volume":"68","author":"Alvarez-Castelao","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"key\n\t\t\t\t20170425173830_awu291-B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2012.08.069","article-title":"Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging","volume":"528","author":"Argyriou","year":"2012","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170425173830_awu291-B4","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","article-title":"Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission","volume":"32","author":"Bae","year":"2012","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425173830_awu291-B5","doi-asserted-by":"crossref","first-page":"33855","DOI":"10.1074\/jbc.274.48.33855","article-title":"Degradation of alpha-synuclein by proteasome","volume":"274","author":"Bennett","year":"1999","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem Int"},{"key":"key\n\t\t\t\t20170425173830_awu291-B7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-4159.2011.07199.x","article-title":"Regulation of alpha-synuclein expression in cultured cortical neurons","volume":"117","author":"Clough","year":"2011","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson's disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t20170425173830_awu291-B9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425173830_awu291-B10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425173830_awu291-B11","first-page":"391438","article-title":"Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders","volume":"2012","author":"Deleidi","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"key\n\t\t\t\t20170425173830_awu291-B12","doi-asserted-by":"crossref","first-page":"e60674","DOI":"10.1371\/journal.pone.0060674","article-title":"Loss of beta-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells","volume":"8","author":"Dermentzaki","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425173830_awu291-B13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Farfel-Becker","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425173830_awu291-B14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","article-title":"Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease","volume":"118","author":"Ferrer","year":"2011","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170425173830_awu291-B15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhl037","article-title":"Miniature synaptic currents become neurotoxic to chronically silenced neurons","volume":"17","author":"Fishbein","year":"2007","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20170425173830_awu291-B16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425173830_awu291-B17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J Neurosci Res"},{"key":"key\n\t\t\t\t20170425173830_awu291-B18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and alpha-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"Ginns","year":"2014","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170425173830_awu291-B19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425173830_awu291-B20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2009.08.032","article-title":"Parkinson's disease: before the motor symptoms and beyond","volume":"289","author":"Korczyn","year":"2010","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170425173830_awu291-B21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","article-title":"Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes","volume":"19","author":"Kuo","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425173830_awu291-B22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.23894","article-title":"G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425173830_awu291-B23","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","article-title":"Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation","volume":"24","author":"Li","year":"2004","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425173830_awu291-B24","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425173830_awu291-B25","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M110.141952","article-title":"Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner","volume":"285","author":"Machiya","year":"2010","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170425173830_awu291-B27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.mp.4000446","article-title":"Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease","volume":"3","author":"Mezey","year":"1998","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20170425173830_awu291-B28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170425173830_awu291-B29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"key\n\t\t\t\t20170425173830_awu291-B30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425173830_awu291-B31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel alpha-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173830_awu291-B32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1471-4159.2003.01574.x","article-title":"Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons","volume":"84","author":"Rideout","year":"2003","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B33","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425173830_awu291-B34","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"issue":"Pt 5","key":"key\n\t\t\t\t20170425173830_awu291-B35","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425173830_awu291-B36","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170425173830_awu291-B37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425173830_awu291-B38","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex vivo and in vivo effects of isofagomine on acid beta-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170425173830_awu291-B40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/138620708786734244","article-title":"Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening","volume":"11","author":"Urban","year":"2008","journal-title":"Comb Chem High Throughput Screen"},{"key":"key\n\t\t\t\t20170425173830_awu291-B41","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","article-title":"Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions","volume":"116","author":"Waxman","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425173830_awu291-B44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","article-title":"A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation","volume":"113","author":"Waxman","year":"2010","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425173830_awu291-B45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170425173830_awu291-B46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170425173830_awu291-B47","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jmb.2008.03.017","article-title":"Characterization of conformational and dynamic properties of natively unfolded human and mouse alpha-synuclein ensembles by NMR: implication for aggregation","volume":"378","author":"Wu","year":"2008","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20170425173830_awu291-B48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"Yap","year":"2013","journal-title":"Mol Genet Metab"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/137\/12\/3235\/13799504\/awu291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T21:13:59Z","timestamp":1503436439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awu291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,28]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,10,28]]},"published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awu291","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,28]]}}}